Effect of Food on Bioavailability of Modified Release Formulations of Imatinib
NCT00420043
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
imatinib
Sponsor
Novartis